Viewing Study NCT00116792

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:27 PM
Ignite Modification Date: 2026-02-01 @ 4:51 AM
Study NCT ID: NCT00116792
Status: UNKNOWN
Last Update Posted: 2007-05-17
First Post: 2005-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions
Sponsor: Gold, Herman K., MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronary Artery Disease View
None Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CAD View
None Diabetes Mellitus View
None Restenosis View
None ppar gamma View
None glitazone View